Track Every Presidential Action. Understand the Impact.

Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States

President Donald J. Trump issued this proclamation after a Commerce Department investigation found that heavy U.S. reliance on imported patented pharmaceuticals and their ingredients threatens national security. The action imposes a 100 percent tariff on covered patented drugs and pharmaceutical ingredients, while allowing lower or zero tariff rates in certain cases, including for companies with approved plans to move production into the United States, companies with agreements on most-favored-nation pricing and onshoring, and some products covered by trade arrangements or special exemptions. It directs the Secretaries of Commerce and Health and Human Services to negotiate and enforce these agreements, set standards for onshoring plans, monitor compliance, and report back to the President. The proclamation was issued to reduce reliance on foreign-made patented medicines and drug ingredients and strengthen domestic pharmaceutical production tied to national security.